The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Interim analysis of clinical data and reasons for initiating relugolix on a cohort of US patients: The OPTYX study.
 
Daniel Eidelberg Spratt
Consulting or Advisory Role - Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Blue Earth Diagnostics; Boston Scientific; Janssen Oncology; Pfizer
Research Funding - Janssen (Inst)
(OPTIONAL) Uncompensated Relationships - NCCN
 
Rana R. McKay
Consulting or Advisory Role - Ambrx; Ambrx; Arcus Biosciences; Astellas Medivation; AstraZeneca; AVEO; Bayer; Blue Earth Diagnostics; Bristol-Myers Squibb; Calithera Biosciences; Caris Life Sciences; Dendreon; Esiai; Exelixis; Janssen; Lilly; Merck; Myovant Sciences; Novartis; Pfizer; Sanofi; Seagen; Sorrento Therapeutics; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tempus; Vividion Therapeutics
Research Funding - Artera (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol Myers Squibb (Inst); Exelixis (Inst); Oncternal Therapeutics (Inst); Tempus (Inst)
 
Ashley Ross
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Blue Earth Diagnostics; Decipher Biosciences; Janssen Biotech; Lantheus Medical Imaging; Myovant Sciences; tempus
Consulting or Advisory Role - Astellas Pharma; BillionToOne
Speakers' Bureau - Tempus
 
Benjamin H Lowentritt
Consulting or Advisory Role - Astellas Pharma; AstraZeneca/MedImmune; Bayer; Blue Earth Diagnostics; Dendreon; Janssen Oncology; Merck; Pfizer; Sumitomo Pharma Oncology; Tolmar
Speakers' Bureau - Astellas Pharma; AstraZeneca/MedImmune; Bayer; Blue Earth Diagnostics; Janssen Oncology; Lantheus Medical Imaging; Merck; Myovant Sciences; Pfizer
Research Funding - Blue Earth Diagnostics; Dendreon; Janssen Oncology; Myovant Sciences
 
Scott C Flanders
Employment - Sumitomo Pharma America
Stock and Other Ownership Interests - Abbvie; Johnson & Johnson; Myovant Sciences
Research Funding - Myovant Science (Inst); Sumitomo Pharma America (Inst)
Travel, Accommodations, Expenses - Myovant Sciences; Sumitomo Pharma America
 
Yajun Emily Zhu
Employment - SMPA
 
Susana Nolley
Employment - Myovant Sciences; Sumitomo Pharma Oncology; Ultragenyx Pharmaceuticals
 
Agnes Hong
Employment - Astellas Pharma; Pfizer
Stock and Other Ownership Interests - CRISPR, Black Diamond Therapeutics
Travel, Accommodations, Expenses - Pfizer and Astellas
 
Sergio C Gatoulis
Employment - Pfizer
Stock and Other Ownership Interests - Orchard Therapeutics
 
Tanya B. Dorff
Consulting or Advisory Role - AstraZeneca; Bayer; Exelixis; Janssen Oncology; Sanofi/Aventis
Research Funding - Pfizer (Inst)